Cytokine responses in a severe case of glandular fever treated successfully with foscarnet combined with prednisolone and intravenous immunoglobulin

Journal of Medical Virology

Volumn 81, Issue 1, 2009, Pages 99-105

  Ma, Christine ^a   Wong, Chun K ^a   Wong, Bonnie C K ^a   Chan, K C Allen ^a   Lun, Samantha W M ^a   Lee, Nelson ^a   Wu, Justin ^a   Cockram, Clive S ^a   Chan, Paul K S ^a   Tang, Julians W ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chemokine; Epstein Barr virus; Hepatitis; Immune mediated response; Infectious mononucleosis; Thrombocytopaenia

Indexed keywords

CXCL9 CHEMOKINE; FOSCARNET; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 12; INTERLEUKIN 4; INTRAGRAM; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PREDNISOLONE; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; VIRUS CAPSID ANTIGEN; VIRUS DNA; ANTIINFLAMMATORY AGENT; ANTIVIRUS AGENT; CYTOKINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOLOGIC FACTOR; VIRUS ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIVIRAL THERAPY; ARTICLE; BLOOD EXAMINATION; CASE REPORT; DISEASE DURATION; DRUG WITHDRAWAL; ECHOGRAPHY; EPSTEIN BARR VIRUS; HEPATOSPLENOMEGALY; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INFECTIOUS MONONUCLEOSIS; MALE; NEUTROPENIA; TH1 CELL; TH2 CELL; VIRUS LOAD; ADOLESCENT; BLOOD; DRUG COMBINATION; IMMUNOLOGY; ISOLATION AND PURIFICATION;

HUMAN HERPESVIRUS 4; MIRIDAE;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; CYTOKINES; DNA, VIRAL; DRUG THERAPY, COMBINATION; FOSCARNET; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INFECTIOUS MONONUCLEOSIS; MALE; PREDNISOLONE; VIRAL LOAD;

EID: 58149230057     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21383     Document Type: Article

References (28)

1. Adams LA, Deboer B, Jeffrey G, Marley R, Garas G. 2006. Ganciclovir and the treatment of Epstein-Barr virus hepatitis. J Gastroenterol Hepatol 21:1758-1760.
2. Andersson J. 1996. Clinical and immunological considerations in Epstein-Barr virus-associated diseases. Scand J Infect Dis Suppl 100:72-82.
3. Andersson J, Ernberg I. 1988. Management of Epstein-Barr virus infections. Am J Med 85:107-115.
4. Attarbaschi T, Willheim M, Ramharter M, Hofmann A, Wahl K, Winkler H, Graninger W, Winkler S. 2003. T cell cytokine profile during primary Epstein-Barr virus infection (infectious mononucleosis). Eur Cytokine Netw 14:34-39.
5. Balfour HH Jr, Holman CJ, Hokanson KM, Lelonek MM, Giesbrecht JE, White DR, Schmeling DO, Webb CH, Cavert W, Wang DH, Brundage RC. 2005. A prospective clinical study of Epstein-Barr virus and host interactions during acute infectious mononucleosis. J Infect Dis 192:1505-1512.
6. Balfour HH Jr, Hokanson KM, Schacherer RM, Fietzer CM, Schmeling DO, Holman CJ, Vezina HE, Brundage RC. 2007. A virologic pilot study of valacyclovir in infectious mononucleosis. J Clin Virol 39:16-21.
7. Biglino A, Sinicco A, Forno B, Pollono AM, Sciandra M, Martini C, Pich P, Gioannini P. 1996. Serum cytokine profiles in acute primary HIV-1 infection, in infectious mononucleosis. Clin Immunol Immunopathol 78:61-69.
8. Brandfonbrener A, Epstein A, Wu S, Phair J. 1986. Corticosteroid therapy in Epstein-Barr virus infection. Effect on lymphocyte class, subset, and response to early antigen. Arch Intern Med 146:337-339.
9. Chan KH, Tam JS, Peiris JS, Seto WH, Ng MH. 2001. Epstein-Barr virus (EBV) infection in infancy. J Clin Virol 21:57-62.
10. Chan CW, Chiang AK, Chan KH, Lau AS. 2003. Epstein-Barr virus-associated infectious mononucleosis in Chinese children. Pediatr Infect Dis J 22:974-978.
11. Corsi MM, Ruscica M, Passoni D, Scarmozzino MG, Gulletta E. 2004. High Th1-type cytokine serum levels in patients with infectious mononucleosis. Acta Virol 48:263-266.
12. Cyran EM, Rowe JM, Bloom RE. 1991. Intravenous gammaglobulin treatment for immune thrombocytopenia associated with infectious mononucleosis. Am J Hematol 38:124-129.
13. Dotevall L, Westin J. 1989. Use of intravenous immunoglobulins in Epstein-Barr virus induced thrombocytopenia. Scand J Infect Dis 21:735-736.
14. Hislop AD, Taylor GS, Sauce D, Rickinson AB. 2007. Cellular responses to viral infection in humans: Lessons from Epstein-Barr virus. Annu Rev Immunol 25:587-617.
15. Kangro HO, Osman HK, Lau YL, Heath RB, Yeung CY, Ng MH. 1994. Seroprevalence of antibodies to human herpesviruses in England and Hong Kong. J Med Virol 43:91-96.
16. Lo YM, Chan LY, Lo KW, Leung SF, Zhang J, Chan AT, Lee JC, Hjelm NM, Johnson PJ, Huang DP. 1999. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res 59:1188-1191.
17. Macsween KF, Crawford DH. 2003. Epstein-Barr virus-recent advances. Lancet Infect Dis 3:131-140.
18. Martro E, Bulterys M, Stewart JA, Spira TJ, Cannon MJ, Thacher TD, Bruns R, Pellett PE, Dollard SC. 2004. Comparison of human herpesvirus 8 and Epstein-Barr virus seropositivity among children in areas endemic and non-endemic for Kaposi's sarcoma. J Med Virol 72:126-131.
19. McGowan JE Jr, Chesney PJ, Crossley KB, LaForce FM. 1992. Guidelines for the use of systemic glucocorticosteroids in the management of selected infections. Working Group on Steroid Use, Antimicrobial Agents Committee, Infectious Diseases Society of America. J Infect Dis 165:1-13.
20. Milone MC, Tsai DE, Hodinka RL, Silverman LB, Malbran A, Wasik MA, Nichols KE. 2005. Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapy. Blood 105:994-996.
21. Ohga S, Nomura A, Takada H, Hara T. 2002. Immunological aspects of Epstein-Barr virus infection. Crit Rev Oncol Hematol 44:203-215.
22. Straus SE, Cohen JI, Tosato G, Meier J. 1993. NIH conference. Epstein-Barr virus infections: Biology, pathogenesis, and management. Ann Intern Med 118:45-58.
23. Takahashi T, Hamasaka N, Harada S, Sugawara N, Yoshimoto M. 2007. Methylprednisolone pulse therapy for severe immune thrombocytopenia associated with infectious mononucleosis. Am J Hematol 82:416-417.
24. Tynell E, Aurelius E, Brandell A, Julander I, Wood M, Yao QY, Rickinson A, Akerlund B, Andersson J. 1996. Acyclovir and prednisolone treatment of acute infectious mononucleosis: A multicenter, double-blind, placebo-controlled study. J Infect Dis 174:324-331.
25. Williams H, Macsween K, McAulay K, Higgins C, Harrison N, Swerdlow A, Britton K, Crawford D. 2004. Analysis of immune activation and clinical events in acute infectious mononucleosis. J Infect Dis 190:63-71.
26. Wong CK, Lam CW, Wu AK, Ip WK, Lee NL, Chan IH, Lit LC, Hui DS, Chan MH, Chung SS, Sung JJ. 2004. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol 136:95-103.
27. Wong CK, Wong BC, Chan KC, Joynt GM, Yap FY, Lam CW, Lee N, Lee SS, Cockram CS, Sung JJ, Chan PK, Lo YM, Tang JW. 2007. Cytokine profile in fatal human immunodeficiency virus-tuberculosis-Epstein-Barr virus-associated hemophagocytic syndrome. Arch Int Med 167:1901-1903.
28. Wright-Browne V, Schnee AM, Jenkins MA, Thall PF, Aggarwal BB, Talpaz M, Estrov Z. 1998. Serum cytokine levels in infectious mononucleosis at diagnosis and convalescence. Leuk Lymphoma 30:583-589.